Gene Therapy for Sickle Cell Disease
Sickle cell disease is an inherited blood disorder that often causes debilitating pain and life-threatening complications. Many patients with the disease make dozens of ER…
Course Category: Hematology & Oncology
Sickle Cell Gene Therapy
New research has led to the approval of sickle cell gene therapy and CHOP has played a big role in both the research and implementation…
Pediatric Urologic Oncology (Long 2024)
At the end of this session, learners will be able to discuss the epidemiology, pathology, diagnosis, prognosis, and treatments of various malignant tumors in pediatric…
New Frontiers: Precision Medicine a ‘Unique Signature’ for Pediatric Cancer Patients
Precision medicine, also known as personalized medicine, has revolutionized how physicians and scientists treat and study disease. According to Theodore W. Laetsch, MD, an oncologist…
Curing Childhood Cancer and Curing Children with Cancer
Carlos Rodriguez-Galindo, MD serves as director of St. Jude Global and chair of the Department of Global Pediatric Medicine. He is also an executive vice…
New Frontiers: At the Forefront of Hemophilia Treatment With CHOP
With a stroll down the hallway at Children’s Hospital of Philadelphia, you run into a tremendous knowledge base and expertise to help answer challenging scientific…
Oncology Rehab
Join us as we speak with Kerri Recker and Kristen Divergilio as they discuss the role that Occupational and Physical Therapy play in the management…
CAR T-Cells: The Creation of a “Living Drug” to Treat Pediatric Leukemia
At the end of this session, learners will be able to understand the process, architecture, manufacture, and trials of chimeric antigen receptor (CAR) T-cells. Speaker:…
Adaptive Immune Responses to SARS-CoV-2 and the Role of Memory T-cell Responses
E. John Wherry, PhD, is the Barbara and Richard Schiffrin President’s Distinguished Professor, Chair of the Department of Systems Pharmacology and Translational Therapeutics in the…
Late Effects of Cancer Therapy and Survivorship
At the end of this session, learners will be able to describe the long-term complications of childhood cancer therapy and specific treatment related risks, as…